Cargando…

Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability

PURPOSE: To develop, test, and validate an instrument for assessing patients’ desirability, acceptability, and adherence to telemedicine in diabetes. PATIENTS AND METHODS: A group of six experts defined the components that needed to be assessed when developing telemedicine platforms aimed at improvi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patrascu, Raul, Albai, Alin, Braha, Adina, Gaita, Laura, Lazar, Sandra, Potre, Ovidiu, Timar, Bogdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654690/
https://www.ncbi.nlm.nih.gov/pubmed/34898981
http://dx.doi.org/10.2147/PPA.S343869
_version_ 1784611915511627776
author Patrascu, Raul
Albai, Alin
Braha, Adina
Gaita, Laura
Lazar, Sandra
Potre, Ovidiu
Timar, Bogdan
author_facet Patrascu, Raul
Albai, Alin
Braha, Adina
Gaita, Laura
Lazar, Sandra
Potre, Ovidiu
Timar, Bogdan
author_sort Patrascu, Raul
collection PubMed
description PURPOSE: To develop, test, and validate an instrument for assessing patients’ desirability, acceptability, and adherence to telemedicine in diabetes. PATIENTS AND METHODS: A group of six experts defined the components that needed to be assessed when developing telemedicine platforms aimed at improving the care of patients with diabetes. The resulting instrument was tested for reliability and construct validity of 114 patients with diabetes and re-tested for reproducibility and consistency on a sub-group of 34 patients. Based on the analysis, the questionnaire’s syntax, phrasing, and flow were improved to obtain optimal assessment results. RESULTS: The resulting questionnaire has three major sections: one for the main evaluated component (acceptability, desirability, and adherence to telemedicine in diabetes), one for collecting socio-economic and demographical information, and one for diabetes history-related data, respectively. The corresponding data for these sections are collected using 29 questions. The developed instrument has a good reliability (Cronbach’s alpha = 0.890), reproducibility (Total score 164 vs 166 points at re-test vs test; Mann–Whitney U p-value = 0.394) and external validity (Spearman’s rho = −0.580; p < 0.001 for correlation with Patient’s Health Questionnaire −9; and Spearman’s rho = −0.516; p < 0.001 for correlation with Generalized Anxiety Disorder – 7). CONCLUSION: The developed questionnaire is a valid and reliable instrument in assessing the patients’ acceptability, desirability, and adherence to telemedicine use in diabetes care. In addition, the use of this instrument in the development of telemedicine platforms may improve and optimize their usage by providing valuable information regarding patients’ preferences and specific needs.
format Online
Article
Text
id pubmed-8654690
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86546902021-12-10 Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability Patrascu, Raul Albai, Alin Braha, Adina Gaita, Laura Lazar, Sandra Potre, Ovidiu Timar, Bogdan Patient Prefer Adherence Original Research PURPOSE: To develop, test, and validate an instrument for assessing patients’ desirability, acceptability, and adherence to telemedicine in diabetes. PATIENTS AND METHODS: A group of six experts defined the components that needed to be assessed when developing telemedicine platforms aimed at improving the care of patients with diabetes. The resulting instrument was tested for reliability and construct validity of 114 patients with diabetes and re-tested for reproducibility and consistency on a sub-group of 34 patients. Based on the analysis, the questionnaire’s syntax, phrasing, and flow were improved to obtain optimal assessment results. RESULTS: The resulting questionnaire has three major sections: one for the main evaluated component (acceptability, desirability, and adherence to telemedicine in diabetes), one for collecting socio-economic and demographical information, and one for diabetes history-related data, respectively. The corresponding data for these sections are collected using 29 questions. The developed instrument has a good reliability (Cronbach’s alpha = 0.890), reproducibility (Total score 164 vs 166 points at re-test vs test; Mann–Whitney U p-value = 0.394) and external validity (Spearman’s rho = −0.580; p < 0.001 for correlation with Patient’s Health Questionnaire −9; and Spearman’s rho = −0.516; p < 0.001 for correlation with Generalized Anxiety Disorder – 7). CONCLUSION: The developed questionnaire is a valid and reliable instrument in assessing the patients’ acceptability, desirability, and adherence to telemedicine use in diabetes care. In addition, the use of this instrument in the development of telemedicine platforms may improve and optimize their usage by providing valuable information regarding patients’ preferences and specific needs. Dove 2021-12-04 /pmc/articles/PMC8654690/ /pubmed/34898981 http://dx.doi.org/10.2147/PPA.S343869 Text en © 2021 Patrascu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Patrascu, Raul
Albai, Alin
Braha, Adina
Gaita, Laura
Lazar, Sandra
Potre, Ovidiu
Timar, Bogdan
Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability
title Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability
title_full Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability
title_fullStr Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability
title_full_unstemmed Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability
title_short Instrument for Assessing Patients’ Desirability, Acceptability, and Adherence to Telemedicine in Diabetes: Development, Validity, and Reliability
title_sort instrument for assessing patients’ desirability, acceptability, and adherence to telemedicine in diabetes: development, validity, and reliability
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654690/
https://www.ncbi.nlm.nih.gov/pubmed/34898981
http://dx.doi.org/10.2147/PPA.S343869
work_keys_str_mv AT patrascuraul instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability
AT albaialin instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability
AT brahaadina instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability
AT gaitalaura instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability
AT lazarsandra instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability
AT potreovidiu instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability
AT timarbogdan instrumentforassessingpatientsdesirabilityacceptabilityandadherencetotelemedicineindiabetesdevelopmentvalidityandreliability